Treatment with AR and STAT-3 inhibitors decreases the effect on PCa cell proliferation induced by AR activation via the IL-6 pathway in a Dihydrotestosterone-independent manner (72,73). This evidence concerns the gene IL6 and posterior cortical atrophy.